Esmolol is an ultra–short-acting beta-blocker indicated for rapid control of tachyarrhythmias and perioperative heart rate management. Its key advantage is very rapid onset and short half-life, allowing immediate titration and quick discontinuation if needed. This provides exceptional control in unstable patients where flexibility is critical. It is widely used in ICU, emergency, and surgical settings, particularly when transient heart rate control is required without long-lasting effects.